Brainstorm Health: Civica RX Focus, Alabama Abortion Law, Johnson & Johnson Pipeline

Brainstorm Health Daily: May 15, 2019 Hello and happy hump day, readers! Last year, a band of health systems .....»»

Category: europeSource: fortuneMay 15th, 2019

Brainstorm Health: Digital Media and ADHD, Johnson & Johnson Shares, Liver Cancer Deaths

Brainstorm Health Daily: July 17, 2018 Hello, readers! This is Sy. One of the biggest questions surrounding social media’s .....»»

Category: europeSource: fortuneJul 17th, 2018

JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its p.....»»

Category: worldSource: nytJan 23rd, 2019

Brainstorm Health: J&J Depression Nasal Spray, Gilead Stock, Anti-Vaxxers

Brainstorm Health Daily: February 12, 2019 Hello, readers. Drug giant Johnson & Johnson enjoyed a 1.6% stock boost on Tuesday after a crucial Food and Drug Administration (FDA) advisory committee vote recommending approval of its in.....»»

Category: europeSource: fortuneFeb 12th, 2019

Brainstorm Health: Drugstore as Doctor, Social Media and Suicide Spike, Missouri Abortion Ban

Brainstorm Health Daily: May 17, 2019 Happy Friday, readers!.....»»

Category: europeSource: fortuneMay 17th, 2019

Ballad Health reports nine-month results: Strong financial performance, capital investment and major regional collaboration

JOHNSON CITY, Tenn., May 15, 2019 (GLOBE NEWSWIRE) -- Ballad Health toda.....»»

Category: earningsSource: benzingaMay 15th, 2019

Brainstorm Health: Roche Spark Deal, Measles Outbreak, Kansas Abortion Ruling

Brainstorm Health Daily: April 26, 2019 Happy Friday, readers! We’ve be.....»»

Category: europeSource: fortuneApr 26th, 2019

Brainstorm Health: Civica Rx Headquarters, Lilly Pfizer Pain Drug, Flu Season

Brainstorm Health Daily: April 19, 2019 Happy Friday, readers! Last year, a coal.....»»

Category: europeSource: fortuneApr 19th, 2019

2 Large Health Care Companies Announce 1st-Quarter Earnings

Johnson & Johnson and UnitedHealth Group top estimates on earnings and revenuesRelated Stocks: JNJ, UNH,.....»»

Category: worldSource: nytApr 16th, 2019

Earnings Outlook: Johnson & Johnson earnings: Drug sales in focus amid worry about generic competition

Johnson & Johnson is set to announce first-quarter earnings Tuesday morning ahead of the market open. Here’s what to expect......»»

Category: topSource: marketwatchApr 15th, 2019

Brainstorm Health: Universal Health Care Vs Innovation, Addyi Alcohol Risk, Ohio Abortion Bill

Brainstorm Health Daily: April 11, 2019 Good afternoon, readers. One of America.....»»

Category: europeSource: fortuneApr 11th, 2019

Best Places to Work Honoree: Alto Health Care Staffing

Alto Health Care Staffing had a busy 2018, as it marked its 15-year anniversary in business. Among the anniversary celebrations, Director of First Impressions Alana Madure-Johnson shared other notable highlights from this past year. The company ex.....»»

Category: topSource: bizjournalsMar 26th, 2019

How healthy is your county? (Gallery)

Philadelphia is again the unhealthiest among Pennsylvania's 67 counties, according to the "County Health Rankings & RoapMaps" report issued Tuesday by the Robert Wood Johnson Foundation and the University of Wisconsin Population Health Institute. .....»»

Category: topSource: bizjournalsMar 19th, 2019

J&J"s stock falls after reports company ordered to pay $29 million to woman dying of cancer

Shares of Johnson & Johnson dropped 1.7% in premarket trade Thursday, after reports that the health care and consumer products giant was ordered by a California court to pay $29 m.....»»

Category: topSource: marketwatchMar 14th, 2019

Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings

Johnson & Johnson reports Q1 results with both revenues and EPS beating estimates. Shares of Johnson & Johnson JNJ decreased 1.2% at market close on Apr 17, 2018 despite beating the Zacks Consensus Esti.....»»

Category: topSource: zacksApr 19th, 2018

Johnson & Johnson Reaffirms Geron"s Imetelstat As Lead Oncology Pipeline Drug

Johnson & Johnson Reaffirms Geron"s Imetelstat As Lead Oncology Pipeline Drug.....»»

Category: topSource: seekingalphaApr 19th, 2018

Baby powder litigation takes new focus with asbestos claims

A $117 million verdict against Johnson & Johnson and.....»»

Category: topSource: moneycentralApr 16th, 2018

Johnson & Johnson"s baby power litigation takes new focus, Reuters reports

See the rest of the story here. provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

J&J Baby Powder litigation takes new focus with asbestos claims

NEW YORK (Reuters) - A $117 million verdict against Johnson & Johnson .....»»

Category: topSource: reutersApr 16th, 2018

Johnson & Johnson: My Favorite Dividend King For Reliable Dividend Growth And Income

Johnson & Johnson (JNJ), together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in th.....»»

Category: blogSource: dividendgrowthinvestorApr 27th, 2018

Pittsburgh health technologies firm names new president

Christopher Johnson has been named president of Pittsburgh-based health care tech firm TeleTracking. Johnson will be in charge of the operational business units for TeleTracking while Chairman and CEO Michael Zamagias will stay in those roles. Johnson h.....»»

Category: topSource: bizjournalsMay 4th, 2018